Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting

Zusammenfassung

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Dermatologic and Ophthalmic Drugs Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues. Date and Time: The meeting will be held on May 23, 2002, from 8:30 a.m. to 5 p.m. Location: Holiday Inn, Kennedy Ballroom, 8777 Georgia Ave., Silver Spring, MD. Contact Person: Karen M. Templeton-Somers, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, (for express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857, 301-827-7001,or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12534. Please call the Information Line for up-to-date information on this meeting. When available, background material for this meeting will be posted on the FDA Web site, one business day prior to the meeting at: www.fda.gov/ohrms/dockets/ac/acmenu.htm. Agenda: The committee will discuss biologic license application, submission tracking number 125036, al